Elicio Therapeutics, Inc. ELTX
1.59 USD -0.04 (-2.45%)
Nov 12, 2026, 2:58 PM EST
1.55 Day range 1.65
1.25 52-week range 16.00
- YTD
- -80.03%
- 1 year
- -82.70%
ELTX revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | 0 | Not meaningful |
| FY 2024 | 2024-12-31 | 0 | 0 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | -28,312,000 | -100.00% |
| FY 2021 | 2021-12-31 | 28,312,000 | 25,432,000 | 883.06% |
| FY 2020 | 2020-12-31 | 2,880,000 | 1,393,000 | 93.68% |
| FY 2019 | 2019-12-31 | 1,487,000 | -2,542,000 | -63.09% |
| FY 2018 | 2018-12-31 | 4,029,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:49.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.